Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand’s disease with octreotide LAR and propranolol

Benzer Materyaller

• Octreotide LAR for severe obscure‐overt gastrointestinal haemorrhage in high‐risk patients on anticoagulation therapy
  Yazar:: Molina‐Infante, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Treatment of congenital fibrinogen deficiency: overview and recent findings
  Yazar:: Tziomalos, Konstantinos, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• von Willebrand factor in upper gastrointestinal tract inflammation.
  Yazar:: Blann, A D
  Baskı/Yayın Bilgisi: (1993)
• Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation
  Yazar:: Classen, Carl Friedrich, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review
  Yazar:: Broder, Michael S, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)